#76 Strong Clinical Relevance
High-quality evidence with meaningful patient or clinical significance.
Clinicians can now counter a common patient concern about cannabis use with evidence-based reassurance, as this study contradicts widespread myths about testosterone suppression. This finding helps providers have more accurate conversations about cannabis’s actual versus perceived health risks, improving clinical credibility and patient trust. Understanding which cannabis-related concerns are evidence-supported versus internet folklore allows clinicians to focus counseling on documented risks like impaired driving or cannabis use disorder rather than unsubstantiated ones.
A recent study challenges the widely circulated claim that cannabis use suppresses testosterone levels in young men, finding no significant association between cannabis consumption and reduced testosterone. This finding is clinically relevant given the frequency with which patients ask about sexual and reproductive health effects of cannabis, and the considerable misinformation circulating online about cannabis-related hormonal changes. While this study provides reassuring evidence regarding acute or short-term testosterone suppression, clinicians should note that the research may not address effects from heavy chronic use or impacts on other aspects of reproductive health such as spermatogenesis or sexual function. The result suggests that testosterone suppression may not be a primary mechanism of cannabis-related reproductive concerns, if such concerns exist, and underscores the need for high-quality evidence on cannabis’s actual endocrine and fertility effects. Clinicians can use this evidence to correct patient misconceptions about cannabis and testosterone while acknowledging gaps in the overall evidence base on cannabis and male reproductive health. When counseling patients about cannabis use, clinicians should distinguish between internet myths and evidence-based harms while remaining transparent about areas where evidence remains limited.
“After two decades of seeing patients worry about this, I can tell you the evidence simply doesn’t support the popular narrative that cannabis use suppresses testosterone in clinically meaningful ways, and perpetuating that myth only erodes trust when we need to have honest conversations about cannabis’s real risks and benefits.”
🧬 The relationship between cannabis use and testosterone has long been a topic of patient concern and clinician counseling, and this recent finding that cannabis does not lower testosterone in young men adds nuance to an oversimplified narrative. However, several important caveats merit consideration: the study’s findings may not generalize across all age groups, frequency of use patterns, or cannabis potency levels, particularly given the dramatic increase in THC concentrations in modern products compared to those available during earlier research. Additionally, absence of effect on baseline testosterone does not rule out potential impacts on other hormonal axes, reproductive function, or sex hormone-binding globulin, and individual variation in metabolism and endocannabinoid system sensitivity remains poorly characterized. Clinicians should avoid over-reassuring patients about hormonal safety while also moving away from categorical statements about testosterone suppression, instead acknowledging the current evidence gap while taking detailed use histories and considering individualized risk assessment based
This topic comes up in consultations often.
Dr. Caplan offers clinical context on evolving cannabis policy and its real-world implications for patients.
Book a consultation →💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
